Natural killer cells in atopic and autoimmune diseases of the skin

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 1-3, 2010, Pages 60-68

  von Bubnoff, Dagmar ^a   Andrès, Emmanuel ^b   Hentges, François ^c   Bieber, Thomas ^a   Michel, Tatiana ^c   Zimmer, Jacques ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

allergy; autoimmunity; Natural killer cells; skin

Indexed keywords

CELL MARKER; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22;

ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE SKIN DISEASE; CELL ACTIVITY; CELL FUNCTION; CYTOKINE PRODUCTION; HUMAN; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PRURITUS; PSORIASIS; TH0 CELL; TH1 CELL;

AUTOIMMUNE DISEASES; DERMATITIS, ATOPIC; HUMANS; KILLER CELLS, NATURAL; PSORIASIS; SKIN;

EID: 73349104119     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.11.020     Document Type: Article

References (127)

1. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Immunol 2 (2002) 850-861
2. Carayannopoulos L.N., and Yokoyama W.M. Recognition of infected cells by natural killer cells. Curr Opin Immunol 16 (2004) 26-33
3. Vivier E., Tomasello E., Baratin M., Walzer T., and Ugolini S. Functions of natural killer cells. Nat Immunol 9 (2008) 503-510
4. Caligiuri M.A. Human natural killer cells. Blood 112 (2008) 461-469
5. Cooper M.A., Colonna M., and Yokoyama W.M. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep 10 (2009) 1103-1110
6. Poli A., Michel T., Thérésine M., Andrès E., Hentges F., and Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126 (2009) 458-465
7. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2 (2002) 957-964
8. Degli-Esposti M.A., and Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take center stage. Nat Rev Immunol 5 (2005) 112-124
9. Yokoyama W.M., Kim S., and French A.R. The dynamic life of natural killer cells. Ann Rev Immunol 22 (2004) 405-429
10. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming. Nat Immunol 5 (2004) 1260-1265
11. Assarsson E., Kambayashi T., Schatzle J.D., Cramer S.O., von Bonin A., Jensen P., et al. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 173 (2004) 174-180
12. Zingoni A., Sornasse T., Cooks B.G., Tanaka Y., Santoni A., and Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 173 (2004) 3716-3724
13. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 2225-2274
14. O'Connor G.M., Hart O.M., and Gardiner C.M. Putting the natural killer cell in its place. Immunology 117 (2006) 1-10
15. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781-790
16. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19 (2001) 197-233
17. Mandelboim O., Lieberman N., Lev M., Paul T., Arnon T.I., Bushkin Y., et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 (2001) 1055-1060
18. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., and Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not NKp30. Eur J Immunol 31 (2001) 2680-2689
19. Arnon T.I., Achdout H., Levi O., Merkel G., Saleh N., Katz G., et al. Inhibition of the NKp30 activating receptor by pp65 from human cytomegalovirus. Nat Immunol 6 (2005) 515-523
20. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., and Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195 (2002) 343-351
21. Brandt C.S., Baratin M., Yi E.C., Kennedy J., Gao Z., Fox B., et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206 (2009) 1495-1503
22. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors for self-MHC molecules. Blood 105 (2005) 4416-4423
23. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-714
24. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 6 (2006) 520-531
25. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25 (2006) 331-342
26. Anderson S.K., Ortaldo J.R., and McVicar D.W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev 181 (2001) 79-89
27. Kane K.P., Silver E.T., and Hazes B. Specificity and function of activating Ly-49 receptors. Immunol Rev 181 (2001) 104-114
28. Perritt D., Robertson S., Gri G., Showe L., Aste-Amezaga M., and Trinchieri G. Cutting edge: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161 (1998) 5821-5824
29. Fehniger T.A., Shah M.H., Turner M.J., Vandeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162 (1999) 4511-4520
30. Loza M.J., Zamai L., Azzoni L., Rosati E., and Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99 (2002) 1273-1281
31. Zhou R., Wei H., and Tian Z. NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J Immunol 178 (2007) 2141-2147
32. Zhang C., Zhang J., and Tian Z. The regulatory effect of natural killer cells: do "NK-reg cells" exist?. Cell Mol Immunol 3 (2006) 241-254
33. Brillard E., Pallandre J.R., Chalmers D., Ryffel B., Radlovic A., Seilles E., et al. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4 + CD25- T lymphocytes. Exp Hematol 35 (2007) 416-425
34. Maroof A., Beattie L., Zubairi S., Svensson M., Stager S., and Kaye P.M. Posttranscriptional regulation of ll10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 29 (2008) 295-305
35. Deniz G., Erten G., Kücüksezer U.C., Kocacik D., Karagiannidis C., Aktas E., et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 180 (2008) 850-857
36. Kheradmand T., Trivedi P.P., Wolf N.A., Roberts P.C., and Swanborg R.H. Characterization of a subset of bone marrow-derived natural killer cells that regulates T cell activation in rats. J Leukoc Biol 83 (2008) 1128-1135
37. Lo C.K., Lam Q.L., Sun L., Wang S., Ko K.H., Xu H., et al. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum 58 (2008) 2700-2711
38. Giuliani M., Giron-Michel J., Negrini S., Vacca P., Durali D., Caignard A., et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS ONE 3 (2008) e2241
39. Roy S., Barnes P.F., Garg A., Wu S., Cosman D., and Vankayalapati R. NK cells lyse regulatory T cells that expand in response to an intracellular pathogen. J Immunol 180 (2008) 1729-1736
40. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31 (2009) 15-23
41. Zenewicz L.A., and Flavell R.A. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 38 (2008) 3265-3268
42. Roark C.L., Simonian P.L., Fontenot A.P., Born W.K., and O'Brien R.L. γδ T cells: an important source of IL-17. Curr Opin Immunol 20 (2008) 353-357
43. Benghiat F.S., Charbonnier L.M., Vokaer B., De Wilde V., and Le Moine A. Interleukin 17-producing T helper cells in alloimmunity. Transplant Rev 23 (2009) 11-18
44. H17 cells in health and disease. J Allergy Clin Immunol 123 (2009) 1004-1011
45. Hanna J., Gonen-Gross T., Fitchett J., Rowe T., Daniels M., Arnon T.I., et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 114 (2004) 1612-1623
46. O'Leary J.G., Goodarzi M., Drayton D.L., and von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7 (2006) 507-516
47. Sun J.C., Beilke J.N., and Lanier L.L. Adaptive immune features of natural killer cells. Nature 457 (2009) 557-561
48. Cooper M.A., Elliott J.M., Keyel P.A., Yang L., Carrero J.A., and Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 106 (2009) 1915-1919
49. Bieber T. Atopic dermatitis. N Engl J Med 358 (2008) 1483-1494
50. Elias P.M., Hatano Y., and Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121 (2008) 1337-1343
51. Sandilands A., Terron-Kwiatkowski A., Hull P.R., O'Regan G.M., Clayton T.H., Watson R.M., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39 (2007) 650-654
52. Akkoc T., de Koning P.J., Ruckert B., Barlan I., Akdis M., and Akdis C.A. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol 121 (2008) 652-658 e1
53. von Bubnoff D., Geiger E., and Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol 108 (2001) 329-339
54. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., et al. IL-22-producing "T22" T cells account for the upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123 (2009) 1244-1252 e2
55. Koga C., Kabashima K., Shiraishi N., Kobayashi M., and Tokura K. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128 (2008) 2625-2630
56. Toda M., Leung D.Y., Molet S., Boguniewicz M., Taha R., Christodoulopoulos P., et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111 (2003) 875-881
57. Oyoshi M.K., He R., Kumar L., Yoon S., and Geha R.S. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 102 (2009) 135-226
58. Wollenberg A., and Klein E. Current aspects of innate and adaptive immunity in atopic dermatitis. Clin Rev Allergy Immunol 33 (2007) 35-44
59. Wollenberg A., Kraft S., Hanau D., and Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 106 (1996) 446-453
60. Wollenberg A., Mommaas M., Oppel T., Schottdorf E.M., Günther S., and Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol 118 (2002) 327-334
61. Fallon P.G., Sasaki T., Sandilands A., Campbell L.E., Saunders S.P., Mangan N.E., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41 (2009) 602-608
62. Kerschenlohr K., Decard S., Przybilla B., and Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 111 (2003) 869-874
63. Novak N., Valenta R., Bohle B., Laffer S., Haberstok J., Kraft S., et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113 (2004) 949-957
64. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., and Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)17, T(H)1 and T(H)2 cells. Nat Immunol 10 (2009) 864-871
65. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., and Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10 (2009) 857-863
66. Nograles K.E., Zaba L.C., Guttman-Yassky E., Fuentes-Duculan J., Suárez-Farinãs M., Cardinale I., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159 (2008) 1092-1102
67. Howell M.D., Wollenberg A., Gallo R.L., Flaig M., Streib J.E., Wong C., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 117 (2006) 836-841
68. Kisich K.O., Carspecken C.W., Fieve S., Boguniewicz M., and Leung D.Y. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 122 (2008) 62-68
69. Rieg S., Steffen H., Seeber S., Humeny A., Kalbacher H., Dietz K., et al. Deficiency of dermicidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174 (2005) 8003-8010
70. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
71. Eyerich K., Foerster S., Rombold S., Seidl H.P., Behrendt H., Hofmann H., et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128 (2008) 2640-2645
72. Luci C., Reynders A., Ivanov I., Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORgammaT on the development of NKp46+ cell populations in gut and skin. Nat Immunol 10 (2009) 75-82
73. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Potier S., Sawa S., and Lochner M. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008) 958-970
74. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009) 722-725
75. Vivier E., Spits H., and Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?. Nat Rev Immunol 9 (2009) 229-234
76. Buentke E., Heffler L.C., Wilson J.L., Wallin R.P., Lofman C., Chambers B.J., et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin- Malassezia-influenced cell interaction. J Invest Dermatol 119 (2002) 850-857
77. Kawakami Y., Tomimuri Y., Yumoto K., Hasegawa S., Ando T., Tagaya Y., et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 206 (2009) 1219-1225
78. Shimada Y., Sato S., Hasegawa M., Tedder T.F., and Takehara K. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity. J Allergy Clin Immunol 104 (1999) 163-168
79. Homey B., Meller S., Savinko T., Alenius H., and Lauerma A. Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem Immunol Allergy 93 (2007) 181-194
80. Purwar R., Werfel T., and Wittmann M. IL-13-stimulated human keratinocytes preferentially attract CD4 + CCR4 + T cells: possible role in atopic dermatitis. J Invest Dermatol 126 (2006) 1043-1051
81. Campbell D.E., Fryga A.S., Bol S., and Kemp A.S. Intracellular interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis. Clin Exp Immunol 115 (1999) 377-382
82. Schmid-Ott G., Jaeger B., Adamek C., Koch H., Lamprecht F., Kapp A., et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 107 (2001) 171-177
83. Katsuta M., Takigawa Y., Kimishima M., Inaoka M., Takahashi R., and Shiohara T. NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 176 (2006) 7736-7744
84. Schuster M., Tschernig T., Krug N., and Pabst R. Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med 161 (2000) 558-566
85. Walker C., Checkel J., Cammisuli S., Leibson P.J., and Gleich G.J. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol 161 (1998) 1962-1969
86. Lambiase A., Normando E.M., Vitiello L., Micera A., Sacchetti M., Perrella E., et al. Natural killer cells in vernal keratoconjunctivitis. Mol Vis 13 (2007) 1562-1567
87. Schmid-Ott G., Jaeger B., Adamek C., Koch H., Lamprecht F., Kapp A., et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 107 (2001) 171-177
88. Aktas E., Akdis M., Bilgic S., Disch R., Falk C.S., Blaser K., et al. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol 140 (2005) 301-309
89. Koning H., Baert M.R., Oranje A.P., Savelkoul H.F., and Neijens H.J. Development of immune functions related to allergic mechanisms in young children. Pediatr Res 40 (1996) 363-375
90. Liao S.Y., Liao T.N., Chiang B.L., Huang M.S., Chen C.C., Chou C.C., et al. Decreased production of IFN gamma and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin Exp Allergy 26 (1996) 397-405
91. Grégoire C., Chasson L., Luci C., Tomasello E., Geissmann F., and Vivier E. The trafficking of natural killer cells. Immunol Rev 220 (2007) 169-182
92. Kimura K., Isowa T., Matsunaga M., Murashima S., and Ohira H. The temporal redistribution pattern of NK cells under acute stress based on CD62L adhesion molecule expression. Int J Psychophysiol 70 (2008) 63-69
93. Nestle F.O., Kaplan D.H., and Barker J. Psoriasis. N Engl J Med 361 (2009) 456-509
94. McGonagle D., and McDermott M.F. A proposed classification of the immunological diseases. PLoS Med 3 (2006) e297
95. Zaba L.C., Fuentes-Duculan J., Eungdamrong N.J., Abello M.V., Novitskaya I., Pierson K.C., et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129 (2009) 79-88
96. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174 (2005) 3695-3702
97. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., and Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
98. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128 (2008) 1207-1211
99. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
100. Boniface K., Blom B., and Liu Y.J. de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 226 (2008) 132-146
101. Nickoloff B.J. The cytokine network in psoriasis. Arch Dermatol 127 (1991) 871-884
102. Reich K., Nestle F.O., Papp K., Ortonne J.P., Evans R., Guzzo C., et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 366 (2005) 1367-1374
103. Bos J.D., de Rie M.A., Teunissen M.B., and Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol 152 (2005) 1098-1107
104. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41 (2009) 211-215
105. Gilhar A., Ullmann Y., Kerner H., Assy B., Shalaginov R., Serafimovich S., et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 119 (2002) 384-391
106. Cameron A.L., Kirby B., Fei W., and Griffiths C.E. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 294 (2002) 363-369
107. Ottaviani C., Nasorri F., Bedini C., de Pita O., Girolomoni G., and Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 36 (2006) 118-128
108. Cameron A.L., Kirby B., and Griffiths C.E. Circulating natural killer cells in psoriasis. Br J Dermatol 149 (2003) 160-164
109. Riccieri V., Spadaro A., Parisi G., Taccari E., Moretti T., Bernardini G., et al. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?. Lupus 9 (2000) 333-337
110. La Gruta N.L., Van Driel I.R., Toh B.H., and Gleeson P.A. The role of natural killer cells in the induction of autoimmune gastritis. Autoimmunity 34 (2001) 147-154
111. Brodin P., Karre K., and Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30 (2009) 143-149
112. Rückert R., Hofmann U., van der Veen C., Bufone-Paus S., and Paus R. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 111 (1998) 25-30
113. Paus R., Ito N., Takigawa M., and Ito T. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 8 (2003) 188-194
114. Gilhar A., and Kalish R.S. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 5 (2006) 64-69
115. Cetin E.D., Savk E., Uslu M., Eskin M., and Karul A. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 31 (2009) 53-60
116. Christoph T., Muller-Rover S., Audring H., Tobin D.J., Hermes B., Cotsarelis G., et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 142 (2000) 862-873
117. Ito T., Ito N., Bettermann A., Tokura Y., Takigawa M., and Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164 (2004) 623-634
118. Ito T., Ito N., Saathoff M., Stampachiacchiere B., Bettermann A., Bufone-Paus S., et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125 (2005) 1139-1148
119. Kalkunte S.S., Mselle T.F., Norris W.E., Wira C.R., Sentman C.L., and Sharma B. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 182 (2009) 4085-4092
120. Ranki A., Kianto U., Kanerva L., Tolvanen E., and Johansson E. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 83 (1984) 7-11
121. Chiarini C., Torchia D., Bianchi B., Volpi W., Caproni M., and Fabbri P. Immunopathogenesis of folliculitis decalvans: clues in early lesions. Am J Clin Pathol 130 (2008) 526-534
122. Ito T., Ito N., Saatoff M., Hashizume H., Fukamizu H., Nickoloff B.J., et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128 (2008) 1196-1206
123. Freyschmidt-Paul P., McElwee K.J., Hoffmann R., Sundberg J.P., Vitacolonna M., Kissling S., et al. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 155 (2006) 515-521
124. Baadsgaard O., and Lindskov R. Circulating lymphocyte subsets in patients with alopecia areata. Acta Derm Venereol 66 (1986) 266-268
125. Takahashi H., Amagai M., Tanikawa A., Suzuki S., Ikeda Y., Nishikawa N., et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol 127 (2007) 324-330
126. Stern J.N.H., Keskin D.B., Barteneva N., Zuniga J., Yunis E.J., and Ahmed A.R. Possible role of natural killer cells in pemphigus vulgaris-preliminary observations. Clin Exp Immunol 152 (2008) 472-481
127. Alecu M., Ursaciuc C., Surcel M., Coman G., Ciotaru D., and Dobre M. CD28 T-cell costimulatory molecule expression in pemphigus vulgaris. J Eur Acad Dermatol Venereol 23 (2009) 288-291